Orchidopexy for congenital cryptorchidism in childhood and adolescence and testicular cancer in adults: an updated systematic review and meta-analysis of observational studies.


Journal

European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 04 01 2023
accepted: 23 03 2023
revised: 15 03 2023
medline: 12 6 2023
pubmed: 30 3 2023
entrez: 29 3 2023
Statut: ppublish

Résumé

Congenital cryptorchidism is a well-established risk factor of testicular malignancies. However, there is still remarkable variability in the measures of associations between of these two clinical entities. The current meta-analysis investigates the up-to-date risk of testicular cancer in adults with a history of surgically corrected congenital cryptorchidism until adolescence. The meta-analysis was conducted with strict criteria for the identification of the congenital cryptorchidism cases that underwent surgery before adulthood. The study was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A search of the PubMed and the Scopus databases was conducted, using a defined strategy, from inception to February 2023. Two independent authors screened the literature and extracted the data, using inclusion and exclusion criteria. Of the 2176 articles identified, 93 articles were fully retrieved, and 6 articles met all the inclusion criteria. The Newcastle-Ottawa scale was applied for the studies' quality assessment. The random-effects model in RevMan 5.4 program was used for the meta-analysis. Three case-control studies and three cohort studies were selected. They included 371,681 patients and 1786 incidents of testicular cancer. The pooled odds ratio (OR) was 3.99 (95% confidence intervals (CI): 2.80-5.71). The heterogeneity was moderate and estimated at 51% with the I-squared statistic. A forest plot and a funnel plot were produced to evaluate the ORs and the probable publication bias, respectively. The mean Newcastle-Ottawa score was 8/9 for all the included reports.  Conclusion: This systematic review and meta-analysis verifies, with an updated estimate, the increased risk of testicular cancer in adults with an orchidopexy history. New evidence on the maldescent laterality supports that the cancer risk remains increased and for the contralateral, unaffected testicle, although to a lesser extent. The orchidopexy in the first year of life prevents the testicular damage and decreases the overall cancer risk. What is Known: • Congenital cryptorchidism is the commonest genitourinary abnormality and a risk factor for testicular cancer. • The most recent meta-analysis reporting this association was in 2013. What is New: • After reviewing literature until February 2023, the association of congenital cryptorchidism with testicular cancer risk in adulthood was verified: odds ratio=3.99 [2.80-5.71], 95% CI. • The meta-analysis highlights the protective role of early orchidopexy and the controversial data about maldescent and testicular cancer laterality.

Identifiants

pubmed: 36988678
doi: 10.1007/s00431-023-04947-9
pii: 10.1007/s00431-023-04947-9
doi:

Types de publication

Meta-Analysis Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2499-2507

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Kim SO, Hwang EC, Hwang IS, Oh KJ, Jung SI, Kang TW, Kwon D, Park K, Bang-Ryu S (2011) Testicular catch-up growth: the impact of orchiopexy age. Urology 78(4):886–889. https://doi.org/10.1016/j.urology.2011.04.057
doi: 10.1016/j.urology.2011.04.057 pubmed: 21762966
Lip SZ, Murchison LE, Cullis PS, Govan L, Carachi R (2013) A meta-analysis of the risk of boys with isolated cryptorchidism developing testicular cancer in later life. Arch Dis Child 98(1):20–26. https://doi.org/10.1136/archdischild-2012-302051
doi: 10.1136/archdischild-2012-302051 pubmed: 23193201
Kolon TF, Herndon CD, Baker LA, Baskin LS, Baxter CG, Cheng EY, Diaz M, Lee PA, Seashore CJ, Tasian GE, Barthold JS (2014) American Urological Association. (2014) Evaluation and treatment of cryptorchidism: AUA guideline. J Urol 192(2):337–45. https://doi.org/10.1016/j.juro.2014.05.005
Hutson JM, Thorup J (2015) Evaluation and management of the infant with cryptorchidism. Curr Opin Pediatr 27(4):520–524. https://doi.org/10.1097/MOP.0000000000000237
doi: 10.1097/MOP.0000000000000237
Loebenstein M, Thorup J, Cortes D, Clasen-Linde E, Hutson JM, Li R (2020) Cryptorchidism, gonocyte development, and the risks of germ cell malignancy and infertility: a systematic review. J Pediatr Surg 55(7):1201–1210. https://doi.org/10.1016/j.jpedsurg.2019.06.023
doi: 10.1016/j.jpedsurg.2019.06.023 pubmed: 31327540
Feyles F, Peiretti V, Mussa A, Manenti M, Canavese F, Cortese MG, Lala R (2014) (2014) Improved sperm count and motility in young men surgically treated for cryptorchidism in the first year of life. Eur J Pediatr Surg 24(5):376–380. https://doi.org/10.1055/s-0033-1349715
doi: 10.1055/s-0033-1349715 pubmed: 23852722
Hensel KO, Caspers T, Jenke AC, Schuler E, Wirth S (2015) Operative management of cryptorchidism: guidelines and reality--a 10-year observational analysis of 3587 cases. BMC Pediatr 15:116. https://doi.org/10.1186/s12887-015-0429-1
Hack WW, Meijer RW, Van Der Voort-Doedens LM, Bos SD, De Kok ME (2003) (2003) Previous testicular position in boys referred for an undescended testis: further explanation of the late orchidopexy enigma? BJU Int 92(3):293–296. https://doi.org/10.1046/j.1464-410x.2003.04317.x
doi: 10.1046/j.1464-410x.2003.04317.x pubmed: 12887487
Wei Y, Wu SD, Wang YC, Lin T, He DW, Li XL, Liu JH, Liu X, Hua Y, Lu P, Zhang DY, Wen S, Wei GH (2016) A 22-year retrospective study: educational update and new referral pattern of age at orchidopexy. BJUInt 118(6):987–993. https://doi.org/10.1111/bju.13588
doi: 10.1111/bju.13588
Dieckmann KP, Pichlmeier U (2004) Clinical epidemiology of testicular germ cell tumors. World J Urol 22:2–14. https://doi.org/10.1007/s00345-004-0398-8
doi: 10.1007/s00345-004-0398-8 pubmed: 15034740
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6(7):e1000100. https://doi.org/10.1371/journal.pmed.1000100
Higgins JPT, Green S (editors) (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Cochrane Collab
Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605. https://doi.org/10.1007/s10654-010-9491-z
doi: 10.1007/s10654-010-9491-z pubmed: 20652370
Review Manager (RevMan) [Computer program] (2020) Version 5.4. Cochrane Collab
Schneuer FJ, Milne E, Jamieson SE, Pereira G, Hansen M, Barker A, Holland AJA, Bower C, Nassar N (2018) Association between male genital anomalies and adult male reproductive disorders: a population-based data linkage study spanning more than 40 years. Lancet Child Adolesc Health 2(10):736–743. https://doi.org/10.1016/S2352-4642(18)30254-2
doi: 10.1016/S2352-4642(18)30254-2 pubmed: 30236382
Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O (2007) Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med 356(18):1835–1841. https://doi.org/10.1056/NEJMoa067588
doi: 10.1056/NEJMoa067588 pubmed: 17476009
Prener A, Engholm G, Jensen OM (1996) Genital anomalies and risk for testicular cancer in Danish men. Epidemiology 7(1):14–9. https://doi.org/10.1097/00001648-199601000-00004
Forman D, Pike MC, Davey G, Dawson S, Baker K, Chilvers CE et al (1994) Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility, and exercise BMJ 308:1393. https://doi.org/10.1136/bmj.308.6941.1393
doi: 10.1136/bmj.308.6941.1393
Strader CH, Weiss NS, Daling JR, Karagas MR, McKnight B (1988) Cryptorchism, orchiopexy, and the risk of testicular cancer. Am J Epidemiol 127(5):1013–1018. https://doi.org/10.1093/oxfordjournals.aje.a114877
doi: 10.1093/oxfordjournals.aje.a114877 pubmed: 2895979
Swerdlow AJ, Huttly SR, Smith PG (1987) Testicular cancer and antecedent diseases. Br J Cancer 55(1):97–103. https://doi.org/10.1038/bjc.1987.20
doi: 10.1038/bjc.1987.20 pubmed: 2880604 pmcid: 2001571
Cook MB, Akre O, Forman D, Madigan MP, Richiardi L, McGlynn KA (2010) A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer–experiences of the son. Int J Epidemiol 39(6):1605–1618. https://doi.org/10.1093/ije/dyq120
doi: 10.1093/ije/dyq120 pubmed: 20660640 pmcid: 2992627
Walsh TJ, Dall'Era MA, Croughan MS, Carroll PR, Turek PJ (2007) Prepubertal orchiopexy for cryptorchidism may be associated with lower risk of testicular cancer. J Urol 178(4 Pt 1):1440–6; discussion 1446. https://doi.org/10.1016/j.juro.2007.05.166
Baird DC, Meyers GJ, Hu JS (2018) Testicular cancer: diagnosis and treatment. Am Fam Physician 97(4):261–268
pubmed: 29671528
Skakkebaek NE, Rajpert-De Meyts E, Main KM (2001) Testicular dysgenesis syndrome: an increasingly common develop- mental disorder with environmental aspects. Hum Reprod 16:972. https://doi.org/10.1093/humrep/16.5.972
doi: 10.1093/humrep/16.5.972 pubmed: 11331648
Akre O, Pettersson A, Richiardi L (2009) Risk of contralateral testicular cancer among men with unilaterally undescended testis: a meta analysis. Int J Cancer 124(3):687–689. https://doi.org/10.1002/ijc.23936
doi: 10.1002/ijc.23936 pubmed: 18973229
Wood HM, Elder JS (2009) Cryptorchidism and testicular cancer: separating fact from fiction. J Urol 181(2):452–461. https://doi.org/10.1016/j.juro.2008.10.074
doi: 10.1016/j.juro.2008.10.074 pubmed: 19084853
Banks K, Tuazon E, Berhane K, Koh CJ, De Filippo RE, Chang A, Kim SS, Daneshmand S, Davis-Dao C, Lewinger JP, Bernstein L, Cortessis VK (2013) Cryptorchidism and testicular germ cell tumors: comprehensive meta-analysis reveals that association between these conditions diminished over time and is modified by clinical characteristics. Front Endocrinol (Lausanne) 18(3):182. https://doi.org/10.3389/fendo.2012.00182
doi: 10.3389/fendo.2012.00182
Ritzén EM, Bergh A, Bjerknes R, Christiansen P, Cortes D, Haugen SE, Jörgensen N, Kollin C, Lindahl S, Läckgren G, Main KM, Nordenskjöld A, Rajpert-De Meyts E, Söder O, Taskinen S, Thorsson A, Thorup J, Toppari J, Virtanen H (2007) Nordic consensus on treatment of undescended testes. Acta Paediatr 96(5):638–643. https://doi.org/10.1111/j.1651-2227.2006.00159.x
doi: 10.1111/j.1651-2227.2006.00159.x pubmed: 17326760
Radmayr C, Dogan HS, Hoebeke P, Kocvara R, Nijman R, Silay S, Stein R, Undre S, Tekgul S (2016) Management of undescended testes: European Association of Urology/European Society for Paediatric Urology Guidelines. J Pediatr Urol 12(6):335–343. https://doi.org/10.1016/j.jpurol.2016.07.014
doi: 10.1016/j.jpurol.2016.07.014 pubmed: 27687532
Allin BSR, Dumann E, Fawkner-Corbett D, Kwok C, Skerritt C (2018) Paediatric Surgery Trainees Research Network. Systematic review and meta-analysis comparing outcomes following orchidopexy for cryptorchidism before or after 1 year of age. BJS Open 2(1):1–12. https://doi.org/10.1002/bjs5.36
Dawson DV, Pihlstrom BL, Blanchette DR (2016) Understanding and evaluating meta-analysis. J Am Dent Assoc 147(4):264–270. https://doi.org/10.1016/j.adaj.2015.10.023
doi: 10.1016/j.adaj.2015.10.023 pubmed: 26705602
Khan S, Memon B, Memon MA (2019) Meta-analysis: a critical appraisal of the methodology, benefits and drawbacks. Br J Hosp Med (Lond) 80(11):636–641. https://doi.org/10.12968/hmed.2019.80.11.636
doi: 10.12968/hmed.2019.80.11.636 pubmed: 31707891

Auteurs

Maria Florou (M)

Second Paediatric Surgery Department, Aristotle University of Thessaloniki, "Papageorgiou" General Hospital, Thessaloniki, Greece. flwrou.mar@gmail.com.

Konstantinos K Tsilidis (KK)

Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, 45110, Ioannina, Greece.

Ekaterini Siomou (E)

Pediatric Department, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.

Triantafyllia Koletsa (T)

Department of Pathology, School of Medicine, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece.

Antonia Syrnioti (A)

Department of Pathology, School of Medicine, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece.

Ioannis Spyridakis (I)

Second Paediatric Surgery Department, Aristotle University of Thessaloniki, "Papageorgiou" General Hospital, Thessaloniki, Greece.

Christos Kaselas (C)

Second Paediatric Surgery Department, Aristotle University of Thessaloniki, "Papageorgiou" General Hospital, Thessaloniki, Greece.

Evangelia E Ntzani (EE)

Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, 45110, Ioannina, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH